MDxHealth SA (NASDAQ:MDXH – Free Report) – Analysts at William Blair dropped their Q3 2024 earnings estimates for MDxHealth in a report released on Thursday, August 22nd. William Blair analyst A. Brackmann now anticipates that the company will earn ($0.26) per share for the quarter, down from their prior forecast of ($0.20). The consensus estimate for MDxHealth’s current full-year earnings is ($1.00) per share. William Blair also issued estimates for MDxHealth’s Q4 2024 earnings at ($0.23) EPS, FY2024 earnings at ($1.11) EPS, Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.17) EPS, Q3 2025 earnings at ($0.17) EPS and FY2025 earnings at ($0.71) EPS.
MDxHealth Stock Performance
NASDAQ:MDXH opened at $2.87 on Monday. MDxHealth has a 1-year low of $2.15 and a 1-year high of $4.64. The company’s fifty day moving average price is $2.71 and its 200-day moving average price is $2.83. The company has a current ratio of 1.69, a quick ratio of 1.53 and a debt-to-equity ratio of 5.43.
Institutional Trading of MDxHealth
About MDxHealth
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.
Recommended Stories
- Five stocks we like better than MDxHealth
- Following Congress Stock Trades
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Consumer Discretionary Stocks Explained
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- Which Wall Street Analysts are the Most Accurate?
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.